Netherlands Biotechnology & Medical Research

TME Pharma NV (ALTME)

Track

Track

TME Pharma NV experienced notable insider activity during September 2025, when CEO van den Ouden acquired shares across five consecutive sessions. These purchases represent the most recent transactions recorded for the firm. Prior to this period, executive buying occurred sporadically throughout 2024, reflecting a consistent pattern of leadership investment in the organization.
Ticker: ALTME Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for TME Pharma NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
van den Ouden DM Managing Director / Chief Executive Officer Director
Transaction date
Purchase
Price
320.98
Quantity 48,481
Value €2,157,941
1.3
van den Ouden DM Managing Director / Chief Executive Officer Director
Transaction date
Purchase
Price
45.54
Quantity 33,592
Value €3,076,168
1.3
van den Ouden DM Managing Director / Chief Executive Officer Director
Transaction date
Purchase
Price
123.89
Quantity 22,153
Value €610,169
1.3
van den Ouden DM Managing Director / Chief Executive Officer Director
Transaction date
Purchase
Price
0.10
Quantity 95,000
Value €9,500
1.3
Ouden, van den Managing Director / Chief Executive Director Director
Transaction date
Purchase
Price
0.09
Quantity 300,000
Value €27,000
2.8
Mangasarian A.A. Managing Director / Chief Executive Officer Director
Transaction date
Purchase
Price
0.05
Quantity 400,000
Value €20,000
2.8
Mangasarian A.A. Managing Director / Chief Executive Director Director
Transaction date
Purchase
Price
0.15
Quantity 85,000
Value €12,750
2.8
Mangasarian A.A. Managing Director / Chief Executive Director Director
Transaction date
Purchase
Price
0.15
Quantity 40,000
Value €6,000
2.8
Mangasarian A.A. Managing Director/Chief Executive Officer Director
Transaction date
Purchase
Price
0.22
Quantity 363,637
Value €80,000
2.8
Mangasarian A.A. Managing Director / Chief Executive Officer Director
Transaction date
Purchase
Price
0.25
Quantity 160,000
Value €40,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-02 2025-09-25 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
48,481
320.98
€2,157,941 		48,481 320.98 €2,157,941
2025-10-02 2025-09-24 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
33,592
45.54
€3,076,168 		33,592 45.54 €3,076,168
2025-10-02 2025-09-23 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
22,153
123.89
€610,169 		22,153 123.89 €610,169
2025-10-02 2025-09-22 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
95,000
0.10
€9,500 		95,000 0.10 €9,500
2025-09-25 2025-09-19 B Purchase
1.3
Ouden, van den

Managing Director / Chief Executive Director

Director
300,000
0.09
€27,000 		300,000 0.09 €27,000
2024-12-16 2024-12-16 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Officer

Director
400,000
0.05
€20,000 		400,000 0.05 €20,000
2024-07-13 2024-07-09 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Director

Director
85,000
0.15
€12,750 		85,000 0.15 €12,750
2024-07-13 2024-07-08 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Director

Director
40,000
0.15
€6,000 		40,000 0.15 €6,000
2024-02-07 2024-02-07 B Purchase
2.8
Mangasarian A.A.

Managing Director/Chief Executive Officer

Director
363,637
0.22
€80,000 		363,637 0.22 €80,000
2023-12-05 2023-12-05 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Officer

Director
160,000
0.25
€40,000 		160,000 0.25 €40,000
Explore more

More insider trading research around TME Pharma NV

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe